Clinical trial transparency--antidote to weaker off-label-promotion rules?

N Engl J Med. 2014 Jul 3;371(1):1-3. doi: 10.1056/NEJMp1402969.
No abstract available

MeSH terms

  • Civil Rights*
  • Clinical Trials as Topic / standards*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence*
  • Drug Labeling / legislation & jurisprudence
  • Government Regulation*
  • Humans
  • Information Dissemination / legislation & jurisprudence
  • Marketing / legislation & jurisprudence
  • Off-Label Use / legislation & jurisprudence*
  • United States
  • United States Food and Drug Administration